NCT06304298View on ClinicalTrials.gov

NLR and PLR Levels Following IPACK Block in Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 30, 2024

Primary Completion Date

January 16, 2025

Study Completion Date

February 10, 2025

Conditions
Knee ArthropathyKnee OsteoarthritisKnee Pain Chronic
Interventions
DRUG

0.9% Sodium Chloride Injection

After spinal anesthesia, the ultrasound-guided iPACK block will be performed with 20ml of 0.9% sodium chloride

DRUG

Ropivacaine 0.2% Injectable Solution

After spinal anesthesia, the ultrasound-guided iPACK block will be performed with 20ml of 0.2% ropivacine

Trial Locations (1)

61-701

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06304298 - NLR and PLR Levels Following IPACK Block in Knee Arthroplasty | Biotech Hunter | Biotech Hunter